
Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.
Take this MedPage Today survey on medical tourism.
So-called medical tourism is a growing phenomenon. Americans by the tens of thousands are heading overseas for low prices on everything from cosmetic procedures to organ transplants and experimental stem-cell therapy. (See






